When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Biotech stocks, in general, again performed dismally in the first quarter of 2022. However, there are some signs of improvement. The lower valuations could present a great buying opportunity once the inevitable strong rebound materializes.
We asked three Motley Fool contributors which biotech stocks they think are good picks to buy in April. Here's why they chose Amgen (NASDAQ: AMGN) , Jazz Pharmaceuticals (NASDAQ: JAZZ) , and Novocure (NASDAQ: NVCR) .